Real-World Adherence and Discontinuation of Oral Antipsychotics and Associated Factors in a National Sample of US Medicare Beneficiaries with Schizophrenia
Christopher Zacker,1 Justin T Puckett,2 Sachin Kamal-Bahl2 1Cerevel Therapeutics, LLC, Cambridge, MA, USA; 2COVIA Health Solutions, Ambler, PA, USACorrespondence: Sachin Kamal-Bahl, COVIA Health Solutions, 915 Brewster Lane Ambler, PA 19002, Tel +1 267-337-4250, Email sachin@coviahealthsolutions.com...
Saved in:
Main Authors: | Zacker C (Author), Puckett JT (Author), Kamal-Bahl S (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2024-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Real-World Effectiveness, Economic, and Humanistic Outcomes of Selected Oral Antipsychotics in Patients with Schizophrenia: A Systematic Review Evaluating Global Evidence
by: Adhikari K, et al.
Published: (2024) -
Racial and Ethnic Disparities in the Burden and Cost of Diabetes for US Medicare Beneficiaries
by: Namino M. Glantz, et al.
Published: (2019) -
Racial disparities in poverty account for mortality differences in US medicare beneficiaries
by: Paul L. Kimmel, et al.
Published: (2016) -
Bariatric surgery outcomes in Medicare beneficiaries
by: Keith Wirth, et al.
Published: (2021) -
A Cross-Sectional Study of Patient Out-of-Pocket Costs for Antipsychotics Among Medicaid Beneficiaries with Schizophrenia
by: Dee Lin, et al.
Published: (2023)